Pharma surges in 2021 Edelman Trust Barometer

Despite a wave of positive recognition at the start of the pandemic, public trust in hospitals and health systems has declined, according to Edelman’s annual Trust Barometer study. But the data also shows that the pharmaceutical industry continues to enjoy an uptick in positive public perception.

The venerable Edelman Trust Barometer, based on an online survey that spans 28 countries and some 33,000 respondents, examines trust and credibility in global institutions. Amid a climate of instability amplified by COVID-19, civil unrest over systemic racism and an economic crisis, this year’s study found that trust has decreased across all types of societal institutions – including business, government and media – and that misinformation has proliferated.

The results showed an unusual trajectory for trust in the health sector. It experienced a boost in May 2020, followed by a decline.

That may say that people are losing their trust in all institutions.

Among the health subsectors singled out in the report – pharma, biotech, hospitals and health systems, consumer health, and commercial insurance – hospitals and health systems seemingly bore the brunt of the backlash.

The current decline in trust for the hospital and health system sector was largely driven by systemic disruption, with many patients unable or unwilling to venture into facilities for non-urgent surgeries or procedures. Emergency room footage provided viewers with a glimpse of the degree of strain on the system.

What the hospital sector should take away from the survey results is that they need to think about improving their commitments to innovation and surrounding communities. It’s essential that hospitals place a greater emphasis on taking care of their employees.

A few questions to ask themselves: How are health systems showing up with how they’re acting, and with the stories they’re telling about the importance of their employee population? How are they really taking care of them and addressing the burnout we know nurses and physicians have? How are they valuing everybody, from the top of the organization to the bottom?

Pharma in the spotlight.

The pandemic, meanwhile, provided the pharma industry with an unprecedented uptick in trust and reputation. Throughout 2020, as pharma companies scrambled to get vaccines developed and approved, the industry began to be perceived as a big part of the solution. Historically, “Big Pharma” was tagged with a rep of too willing to take advantage of patients through high drug prices.

In the U.S., pharma had a nine-point increase in trust, which is considerable. People believe this sector is really driving the most critical solution for the global community right now.

Despite those gains, however, pharma remains in what Edelman characterized as “distrusted territory.”

They’ve had progress, but they haven’t risen up into trusted territory. What that says to us is that there’s so much opportunity to take these trust gains and look at what they can do in the next 12 to 24 months, to think about the lessons they’ve learned during COVID.

The study results also revealed a heightened expectation on business – including healthcare and pharma companies – to take the lead in addressing broad societal issues, like health inequities and needed improvements to the healthcare system. More than 60% of people in the U.S. said that the country would not be able to overcome its challenges without the business community stepping in.

We now have this understanding that there’s an interconnectedness between the health of our communities and our people, and the health of our economy. There has to be an appreciation going forward of how we address things to improve public health for all communities, with equity at the center.

That means pharma and healthcare companies should prioritize employee well-being and allow CEOs to be heard early and often. Just as important is the need for these organizations to create and deliver trustworthy content.

The secret for Pharma may lie on an inside-out approach where the industry harness the positive pride that employees have, and help them to share stories externally. Give them opportunities to engage and take action, and then harness the pride they have in their companies playing a bigger role when it comes to societal issues and public health issues.





HCP Digital Engagement: Trends and Effective Strategies for Medical Affairs Pharma Teams.  
Data-driven insights and an optimized orchestration of content delivery and channels are essential for Pharma to expand their relationships with modern HCPs.
AI’s Transformational Impact on the Patient-Physician Relationship.

The Transformational Impact of Artificial Intelligence on the Relationship Between Physicians and Patients.In today’s ever-evolving healthcare landscape, the integration of…

What is Medical Communications? The definitive guide.

Medical Communications. The demand for clear and integrated dissemination of scientific knowledge is critical for the Pharmaceutical industry. Medical communications—or…

Enhancing engagement with healthcare professionals (HCPs): How AI is transforming Pharma relationships.

Pharmaceutical companies are progressively turning to the use of Artificial Intelligence (AI) as a tool to transform several aspects of…

Six communication trends Pharma needs to watch in 2024.

Six Communication trends Pharma needs to watch in 2024.As we approach 2024, the Pharma industry’s focus on developing and maintaining…

0 +



0 +




0 +



Whether you’re looking for effective solutions to transition F2F meetings to a virtual or online environment, support with clinical trials, medical advisory boards, symposia, key opinion leader (KOL) management, internal medical training, medical writing or speaker training programs and more, count on our 16-year experience and expertise over 40 therapeutic areas.

SDM also offers strategic consulting services and can help with communication and engagement of your target audiences as part of market development opportunities.

Discover why over 95% of clients are “Extremely Satisfied” with SDM and over 90% say the agency deliver “Much more than expected”.